This phenomenon has been shown to be present in chronic lung diseases such as COPD and IPF (Zhou et al., 2010), and our data from CPFE explanted lung tissue reveal evidence of purinergic remodeling consistent with increased ADORA2B expression. Here, ADORA2B is linked to chronic obstructive pulmonary disease.